Exploration phase to build an MMS enabling environment
Johns Hopkins Bloomberg School of Public Health is conducting a trial to evaluate the impact of an integrated intervention of Calcium + 81 mg aspirin + MMS (“CAMMS”) compared to IFA on preterm birth. The trial will be conducted in Zimbabwe (partnering with Institute for Maternal and Child Health Research), Burkina Faso (partnering with L’Institut Africain de Santé Publique (IASP), and Pakistan (partnering with Dept Community Health Sciences, Aga Khan University). The trials will enroll about 10,000 pregnant women early in pregnancy and follow them to delivery.
- Regions (Provinces/Districts): 1 province
- Start Date: January 2021
- End Date: ongoing